Correlation Between Edgewell Personal and Catalyst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Edgewell Personal and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewell Personal and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewell Personal Care and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on Edgewell Personal and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewell Personal with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewell Personal and Catalyst Pharmaceuticals.
Diversification Opportunities for Edgewell Personal and Catalyst Pharmaceuticals
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Edgewell and Catalyst is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Edgewell Personal Care and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and Edgewell Personal is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewell Personal Care are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of Edgewell Personal i.e., Edgewell Personal and Catalyst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Edgewell Personal and Catalyst Pharmaceuticals
Considering the 90-day investment horizon Edgewell Personal Care is expected to under-perform the Catalyst Pharmaceuticals. In addition to that, Edgewell Personal is 1.36 times more volatile than Catalyst Pharmaceuticals. It trades about -0.06 of its total potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about -0.06 per unit of volatility. If you would invest 2,345 in Catalyst Pharmaceuticals on April 25, 2025 and sell it today you would lose (188.00) from holding Catalyst Pharmaceuticals or give up 8.02% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 98.39% |
Values | Daily Returns |
Edgewell Personal Care vs. Catalyst Pharmaceuticals
Performance |
Timeline |
Edgewell Personal Care |
Catalyst Pharmaceuticals |
Edgewell Personal and Catalyst Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Edgewell Personal and Catalyst Pharmaceuticals
The main advantage of trading using opposite Edgewell Personal and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewell Personal position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.Edgewell Personal vs. European Wax Center | Edgewell Personal vs. Inter Parfums | Edgewell Personal vs. Mannatech Incorporated | Edgewell Personal vs. Spectrum Brands Holdings |
Catalyst Pharmaceuticals vs. Amylyx Pharmaceuticals | Catalyst Pharmaceuticals vs. Axsome Therapeutics | Catalyst Pharmaceuticals vs. Exelixis | Catalyst Pharmaceuticals vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Global Correlations Find global opportunities by holding instruments from different markets |